Revenue beat, margin miss; Q1 solid but guides lower on annual EBITDA
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Beat FY27 15% revenue target in Q1 alone; cut margin guidance 28%→21-23% mid-call; QRSAM/NGC delays expected but material.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 delivered strong 24.9% YoY revenue growth, beating 15% guidance, but margin compressed to 25.8% EBITDA vs. prior 28% guided—management cut FY27 margin guidance to 21-23%. Order inflows lean (₹3.8K Cr) due to prior-year spillover timing, not structural, but QRSAM delayed to Sept and large naval platforms await CCS approval. Long-term order pipeline (₹72K Cr book, ₹55K Cr FY27 target including ₹30K QRSAM) is credible and well-distributed. Key risk: program delays and margin compression absorption via product mix.
₹5533 Cr
Revenue · +25.27% YoY₹1048 Cr
Reported PAT · +8.17% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Revenue grew 25.27% YoY in Q1
OVERSTATEDDelivered result shows 24.9% YoY growth
PAT grew 8.17% YoY in Q1
UnderstatedDelivered result shows 8.8% YoY growth (better than stated)
EBITDA margin 25.83% in Q1
METDelivered OPM 25.0%, consistent with Q1 margin stated
Margin guidance of 28% will be crossed by year-end
MISSClosing remarks guide 21-23% EBITDA margin for FY27, conflicting prior 28% statement
Order inflow weakness due to timing, not structural
METGot ₹3,754 Cr, explained as planned (vs ₹25K-₹30K prior year)
Earnings quality
What changed since the last call
EBITDA margin guidance
DowngradePrior FY26 call: 28%+ EBITDA. Q1 FY27 closing: 21-23% EBITDA. Mid-call reaffirmed 28% but official closing lower.
QRSAM timing
DowngradeExpected by March 2026, now says Q1/Q2, max Sept 2026; waiting on CCS approval only
Order inflow cadence
Neutral₹3,754 Cr Q1 (vs ₹25K prior-year Q1) explained as planned, due to front-loaded prior FY; annual ₹55K+ target reaffirmed
Export revenue outlook
UpgradeGuided USD 300 million export revenue for FY27 (vs $465M order book); target 10% of revenue within 5 years
The Q&A
Analysts probed lean order inflow and margin compression but management held steady on timing explanation. Limited skepticism on guidance reaffirmation. One analyst raised Tejas delivery risk to LRU pipeline; management reassured surplus supply mitigates risk.
Order inflow slump — Amit Dixit, Goldman Sachs
AnsweredTiming: FY26 received ₹25K expected but got ₹30K+ in Jan-Mar; this year structured to get only ₹3K+ planned. QRSAM still on track for Sept by CCS.
Margin decline YoY — Mohit Pandey, Citi Research
AnsweredProduct mix only, not input cost. Reaffirm 28% EBITDA margin guidance for FY.
Order book split — Kavish Parekh, 360 ONE Capital
Partial30/30/30 split evenly; margin spread uniform across services due to subsystem diversity. Cannot isolate by product.
Counter-drone market — Kavish Parekh, 360 ONE Capital
AnsweredFocused on hard-kill D4 laser/microwave DEW solutions. 80% of 2kW laser orders already supplied. Microwave DEW prototype ready. De facto leader in large complex systems.
Naval platform orders — Harshit Patel, Equirus Securities
DodgedToo early; still in config finalization with DRDO/Navy. Clarity within 1 year for NGD. Programs beyond FY28-29.
Netra 2 competition — Harshit Patel, Equirus Securities
AnsweredLost bid, Adani L1. BEL will supply subsystems (Radar, EW, Data Links) to Adani and DRDO. SI role missed, subsystem strength remains.
Missile market opening to private sector — Bhalchandra Shinde, Motilal Oswal
PartialBEL not established in missiles but aspiring. Collaborating with private partners as DCPP. Electronics are complex; BEL leads in subsystems.
Tejas delivery delays — Jyoti Gupta, Ashika Group
AnsweredNo; BEL supplied 80%+ of required LRUs. Bottleneck is engine, not BEL. Can adjust production if HAL signals slowness.
Pay commission impact — Atul Tiwari, JPMorgan
AnsweredJan 2027 wage revision; FY27 provision for 3 months. Employee cost-to-revenue stays ~12% due to revenue growth absorption.
Supply chain inflation — Vikash Singh, ICICI Securities
AnsweredNo; indigenization drive will offset. Target zero module-level imports in 5 years. 78-80% already domestic.
AMCA program — Vikash Singh, ICICI Securities
AnsweredExtended 2 months; now Aug 27, 2026. Pricing and sub-module clarity achieved with L&T; apex meetings done.
LRSAM execution — Aritra Banerjee, Nomura
AnsweredNo delays; delivery schedule spreads to this year. Majority of ₹3K Cr (₹2.1-2.3K Cr) planned FY27.
FY27 margin achievement — Bhavya Gandhi, Bajaj Alternate
PartialYes; 25-31% quarterly variability expected. Will cross 28% by year-end (conflicting with closing 21-23% stated).
Export growth — Rahul, Macquarie
AnsweredRadios, Satcom, DEW, TR modules, WLR systems. USD 465M order book, leads 4-5x more. FY27 target USD 300M; aim 10% of revenue in 5 years.
FY27 revenue beat — Shriram Kapoor, Jefferies
AnsweredTarget is 15%; may surprise by 0.5-1.5%. Confident to meet or exceed.
Raw material cost inflation — Vipul Shah, Sumangal Investments
AnsweredProduct mix; historically 50-59%, typically 55%. Variability ±3-4% normal. Analyzed thoroughly, no input cost pressure.
Guidance
FY27 15% revenue growth (or match/exceed)
HighAlready beat in Q1 at 24.9%; management confident on full-year 15%+ despite Q-on-Q lumping
FY27 EBITDA margin 21-23% (cut from prior 28%)
MediumQ1 at 25.83%; management says will cross 28% by year-end (conflicting). Product mix cited as driver of variability 25-31%.
Capex >₹1,200 Cr for FY27 production/infrastructure
HighSeparate from R&D; dedicated to production capacity, infrastructure investment
Risks the call surfaced
Program delay risk
HighQRSAM pushed from March to Sept; NGC/P75I await CCS approval. Large orders (₹30K, ₹15K+ Cr) critical to ₹55K FY27 target. Delays would materially miss order guidance.
Margin compression
MediumQ1 EBITDA 25.83% below 28% prior guidance. Closing remarks guide 21-23% for FY27 (vs mid-call reaffirm of 28%). Product mix cited but detail sparse. Raw material costs up 8-10% YoY; management denies pressure but attribution vague.
Order inflow volatility
MediumQ1 inflow ₹3,754 Cr vs. prior-year ₹25-30K Cr typical first quarter. Explained as prior-year front-loading (received ₹30K+ in Jan-Mar instead of March deadline). Structural risk low but timing creates execution risk if H2 large orders slip.
Execution risk on large programs
MediumKusha still in DRDO testing phase; AMCA RFP due Aug 27 (extended). Tejas LRU inventory sufficient but engine delays signal platform risk. These are 2-3 year build programs; execution slippage common.
Competition and competitive displacement
LowBEL lost Netra 2 system integrator role to Adani but retained subsystem supply. Private sector (Zen Technologies, startups) now entering counter-drone and missile electronics. Competitive intensity rising.
Management
Score 7/10. Clear on guidance and strategy; transparent on delays (QRSAM, order inflow timing). Inconsistent on margin guidance (28% mid-call vs 21-23% closing). Evasive on product-mix details. Beat FY27 revenue target in Q1 (24.9% vs 15%); on track for annual order target but Q1 lean. Margins compressed Q1; full-year target downgraded. 15-year track record of R&D ROI cited; execution credible on subsystems.
1 · Sep 2026
QRSAM order expected; CCS approval pending
2 · Q2-Q3 FY27
Shatrughat & Samaghat: ₹9,000 Cr order expected
3 · Q3 FY27
NGC or P75I naval platform order; 100% confidence on ≥1, >50% on both
Key risk: program delays and margin compression absorption via product mix.
Informational and educational content only. Not investment advice.